KEGG Orthology (KO) - Gallus gallus (chicken)

[ Brite menu | Organism menu | Download htext | Download json ]
    

1st Level  2nd Level  3rd Level  4th Level 

     KO
 Metabolism
 
   Carbohydrate metabolism
 
   Energy metabolism
 
   Lipid metabolism
     00061 Fatty acid biosynthesis [PATH:gga00061]
     00062 Fatty acid elongation [PATH:gga00062]
     00071 Fatty acid degradation [PATH:gga00071]
     00072 Synthesis and degradation of ketone bodies [PATH:gga00072]
     00073 Cutin, suberine and wax biosynthesis
     00100 Steroid biosynthesis [PATH:gga00100]
     00120 Primary bile acid biosynthesis [PATH:gga00120]
     00121 Secondary bile acid biosynthesis
     00140 Steroid hormone biosynthesis [PATH:gga00140]
     00561 Glycerolipid metabolism [PATH:gga00561]
     00564 Glycerophospholipid metabolism [PATH:gga00564]
     00565 Ether lipid metabolism [PATH:gga00565]
     00600 Sphingolipid metabolism [PATH:gga00600]
     00590 Arachidonic acid metabolism [PATH:gga00590]
       770292 PLA2G1BL; phospholipase A2, minor isoenzyme
       426747 PLA2G2E; group IIE secretory phospholipase A2 precursor
       416425 PLA2G10; group 10 secretory phospholipase A2 precursor
       423705 PLA2G12B; group XIIB secretory phospholipase A2-like protein isoform X1
       771655 PLA2G5; calcium-dependent phospholipase A2 precursor
       426748 PLA2G2A; phospholipase A2, membrane associated precursor
       416980 PLA2G1B; phospholipase A2 group IB precursor
       418356 PLA2G10L; phospholipase A2
       100858782 PROCA1; protein PROCA1
       107051573 PLA2G3; group 3 secretory phospholipase A2
       423227 PLA2G4EL6; cytosolic phospholipase A2 epsilon
       396394 PLA2G4A; cytosolic phospholipase A2
       428870 PLA2G4EL3; cytosolic phospholipase A2 epsilon
       771574 PLA2G4EL2; cytosolic phospholipase A2 epsilon isoform X1
       428871 PLA2G4F; cytosolic phospholipase A2 zeta isoform X2
       771560 PLA2G4EL4; cytosolic phospholipase A2 epsilon
       423229 PLA2G4EL1; cytosolic phospholipase A2 epsilon isoform X1
       423226 PLA2G4EL7; cytosolic phospholipase A2 epsilon
       771552 PLA2G4EL5; cytosolic phospholipase A2 epsilon
       101749229 PLA2G4B; cytosolic phospholipase A2 beta isoform X1
       418028 PLA2G6; 85/88 kDa calcium-independent phospholipase A2
       427752 PTGS1; prostaglandin G/H synthase 1 isoform X2
       396451 PTGS2; prostaglandin G/H synthase 2 isoform 1 precursor
       417193 PTGES; prostaglandin E synthase
       417214 PTGES2; prostaglandin E synthase 2
       100859133 PTGES3; prostaglandin E synthase 3
       418512 CBR1; carbonyl reductase [NADPH] 1
       418101 TBXAS1; thromboxane-A synthase isoform X2
       374110 PTGDS; prostaglandin-H2 D-isomerase precursor
       395863 HPGDS; hematopoietic prostaglandin D synthase
       423769 ALOX5; arachidonate 5-lipoxygenase isoform X1
       417918 LTA4H; leukotriene A-4 hydrolase
       770619 LTC4S; leukotriene C4 synthase isoform X2
       770665 LTC4SL; leukotriene C4 synthase
       416943 GGT5; glutathione hydrolase 5 proenzyme isoform X3
       416945 GGT1; glutathione hydrolase 1 proenzyme isoform X1
       424643 GPX7; glutathione peroxidase 7
       427638 GPX3; glutathione peroxidase 3 precursor
       100857115 GPX1; glutathione peroxidase 1
       100857454 GPX2; glutathione peroxidase 2
       426170 GPX8; probable glutathione peroxidase 8 isoform X2
       424676 CYP2J23; cytochrome P450 2J23
       424729 CYP2J19; cytochrome P450 2J2
       424677 CYP2J22; cytochrome P450, family 2, subfamily J, polypeptide 22
       422528 CYP2U1; cytochrome P450 2U1
       425997 ALOX15B; hydroperoxide isomerase ALOXE3
       414833 CYP2C45; cytochrome P-450 2C45
       100858007 RP11-400G3.5; cytochrome P450 2C9-like
       421999 EPHX2; bifunctional epoxide hydrolase 2
K01047 PLA2G; secretory phospholipase A2 [EC:3.1.1.4]
K01047 PLA2G; secretory phospholipase A2 [EC:3.1.1.4]
K01047 PLA2G; secretory phospholipase A2 [EC:3.1.1.4]
K01047 PLA2G; secretory phospholipase A2 [EC:3.1.1.4]
K01047 PLA2G; secretory phospholipase A2 [EC:3.1.1.4]
K01047 PLA2G; secretory phospholipase A2 [EC:3.1.1.4]
K01047 PLA2G; secretory phospholipase A2 [EC:3.1.1.4]
K01047 PLA2G; secretory phospholipase A2 [EC:3.1.1.4]
K01047 PLA2G; secretory phospholipase A2 [EC:3.1.1.4]
K01047 PLA2G; secretory phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16343 PLA2G6; calcium-independent phospholipase A2 [EC:3.1.1.4]
K00509 PTGS1; prostaglandin-endoperoxide synthase 1 [EC:1.14.99.1]
K11987 PTGS2; prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1]
K15729 PTGES; microsomal prostaglandin-E synthase 1 [EC:5.3.99.3]
K05309 PTGES2; microsomal prostaglandin-E synthase 2 [EC:5.3.99.3]
K15730 PTGES3; cytosolic prostaglandin-E synthase [EC:5.3.99.3]
K00079 CBR1; carbonyl reductase 1 [EC:1.1.1.184 1.1.1.189 1.1.1.197]
K01832 TBXAS1; thromboxane-A synthase [EC:5.3.99.5]
K01830 PTGDS; prostaglandin-H2 D-isomerase [EC:5.3.99.2]
K04097 HPGDS; prostaglandin-H2 D-isomerase / glutathione transferase [EC:5.3.99.2 2.5.1.18]
K00461 ALOX5; arachidonate 5-lipoxygenase [EC:1.13.11.34]
K01254 LTA4H; leukotriene-A4 hydrolase [EC:3.3.2.6]
K00807 LTC4S; leukotriene-C4 synthase [EC:4.4.1.20]
K00807 LTC4S; leukotriene-C4 synthase [EC:4.4.1.20]
K18592 GGT1_5; gamma-glutamyltranspeptidase / glutathione hydrolase / leukotriene-C4 hydrolase [EC:2.3.2.2 3.4.19.13 3.4.19.14]
K18592 GGT1_5; gamma-glutamyltranspeptidase / glutathione hydrolase / leukotriene-C4 hydrolase [EC:2.3.2.2 3.4.19.13 3.4.19.14]
K00432 gpx; glutathione peroxidase [EC:1.11.1.9]
K00432 gpx; glutathione peroxidase [EC:1.11.1.9]
K00432 gpx; glutathione peroxidase [EC:1.11.1.9]
K00432 gpx; glutathione peroxidase [EC:1.11.1.9]
K00432 gpx; glutathione peroxidase [EC:1.11.1.9]
K07418 CYP2J; cytochrome P450 family 2 subfamily J [EC:1.14.14.1]
K07418 CYP2J; cytochrome P450 family 2 subfamily J [EC:1.14.14.1]
K07418 CYP2J; cytochrome P450 family 2 subfamily J [EC:1.14.14.1]
K07422 CYP2U1; cytochrome P450 family 2 subfamily U polypeptide 1
K08022 ALOX15B; arachidonate 15-lipoxygenase (second type) / 8-lipoxygenase (S-type) [EC:1.13.11.33 1.13.11.-]
K07413 CYP2C; cytochrome P450 family 2 subfamily C [EC:1.14.14.1]
K07413 CYP2C; cytochrome P450 family 2 subfamily C [EC:1.14.14.1]
K08726 EPHX2; soluble epoxide hydrolase / lipid-phosphate phosphatase [EC:3.3.2.10 3.1.3.76]
     00591 Linoleic acid metabolism [PATH:gga00591]
     00592 alpha-Linolenic acid metabolism [PATH:gga00592]
     01040 Biosynthesis of unsaturated fatty acids [PATH:gga01040]
     01004 Lipid biosynthesis proteins [BR:gga01004]
 
   Nucleotide metabolism
 
   Amino acid metabolism
 
   Metabolism of other amino acids
 
   Glycan biosynthesis and metabolism
 
   Metabolism of cofactors and vitamins
 
   Metabolism of terpenoids and polyketides
 
   Biosynthesis of other secondary metabolites
 
   Xenobiotics biodegradation and metabolism
 
   Enzyme families
 
 Genetic Information Processing
 
 Environmental Information Processing
 
   Membrane transport
 
   Signal transduction
     02020 Two-component system
     02022 Two-component system
     04014 Ras signaling pathway
     04015 Rap1 signaling pathway
     04010 MAPK signaling pathway [PATH:gga04010]
     04013 MAPK signaling pathway - fly
     04016 MAPK signaling pathway - plant
     04011 MAPK signaling pathway - yeast
     04012 ErbB signaling pathway [PATH:gga04012]
     04310 Wnt signaling pathway [PATH:gga04310]
     04330 Notch signaling pathway [PATH:gga04330]
     04340 Hedgehog signaling pathway [PATH:gga04340]
     04341 Hedgehog signaling pathway - fly
     04350 TGF-beta signaling pathway [PATH:gga04350]
     04390 Hippo signaling pathway
     04391 Hippo signaling pathway -fly
     04392 Hippo signaling pathway - multiple species
     04370 VEGF signaling pathway [PATH:gga04370]
       395909 VEGFA; vascular endothelial growth factor A isoform 1 precursor
       395323 KDR; vascular endothelial growth factor receptor 2 precursor
       425978 SH2D2A; SH2 domain-containing protein 2A
       419175 PLCG1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X1
       776273 1-phosphatidylinositol 4
       415805 PLCG2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2
       417430 PRKCA; protein kinase C alpha type
       416567 PRKCB; protein kinase C beta type isoform X1
       427803 SPHK1; sphingosine kinase 1
       396229 HRAS; GTPase HRas precursor
       418207 KRAS; GTPase KRas
       419885 NRAS; GTPase NRas precursor
       396245 RAF1; RAF proto-oncogene serine/threonine-protein kinase
       415549 MAP2K1; dual specificity mitogen-activated protein kinase kinase 1
       396349 MAP2K2; dual specificity mitogen-activated protein kinase kinase 2
       373953 MAPK1; mitogen-activated protein kinase 1
       423227 PLA2G4EL6; cytosolic phospholipase A2 epsilon
       396394 PLA2G4A; cytosolic phospholipase A2
       428870 PLA2G4EL3; cytosolic phospholipase A2 epsilon
       771574 PLA2G4EL2; cytosolic phospholipase A2 epsilon isoform X1
       428871 PLA2G4F; cytosolic phospholipase A2 zeta isoform X2
       771560 PLA2G4EL4; cytosolic phospholipase A2 epsilon
       423229 PLA2G4EL1; cytosolic phospholipase A2 epsilon isoform X1
       423226 PLA2G4EL7; cytosolic phospholipase A2 epsilon
       771552 PLA2G4EL5; cytosolic phospholipase A2 epsilon
       101749229 PLA2G4B; cytosolic phospholipase A2 beta isoform X1
       378890 PPP3CB; serine/threonine-protein phosphatase 2B catalytic subunit beta isoform
       395113 PPP3CA; serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X1
       378804 PPP3R1; calcineurin subunit B type 1
       419346 NFATC2; nuclear factor of activated T-cells, cytoplasmic 2 isoform X2
       396451 PTGS2; prostaglandin G/H synthase 2 isoform 1 precursor
       396416 PTK2; focal adhesion kinase 1
       770341 SHC2; SHC-transforming protein 2 isoform X2
       395832 PXN; paxillin
       395917 CDC42; cell division control protein 42 homolog precursor
       417739 MAPK11; mitogen-activated protein kinase 11
       421183 MAPK14; mitogen-activated protein kinase 14 isoform X1
       769763 MAPK12; mitogen-activated protein kinase 12
       771145 MAPK13; mitogen-activated protein kinase 13 isoform X1
       419847 MAPKAPK2; MAP kinase-activated protein kinase 2 isoform X1
       415917 MAPKAPK3; MAP kinase-activated protein kinase 3
       396227 HSPB1; heat shock protein beta-1
       396442 SRC; proto-oncogene tyrosine-protein kinase Src
       424971 PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
       419444 PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
       424826 PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
       429096 PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma isoform X2
       771142 PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta
       427171 PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X2
       395871 RAC1; ras-related C3 botulinum toxin substrate 1
       418044 RAC2; ras-related C3 botulinum toxin substrate 2
       395870 RAC3; ras-related C3 botulinum toxin substrate 3
       395928 AKT1; RAC-alpha serine/threonine-protein kinase
       421497 AKT3; RAC-gamma serine/threonine-protein kinase isoform X1
       426970 CASP9; caspase-9
K05448 VEGFA; vascular endothelial growth factor A
K05098 KDR; kinase insert domain protein receptor [EC:2.7.10.1]
K08273 SH2D2A; SH2 domain protein 2A
K01116 PLCG1; phosphatidylinositol phospholipase C, gamma-1 [EC:3.1.4.11]
K01116 PLCG1; phosphatidylinositol phospholipase C, gamma-1 [EC:3.1.4.11]
K05859 PLCG2; phosphatidylinositol phospholipase C, gamma-2 [EC:3.1.4.11]
K02677 PRKCA; classical protein kinase C alpha type [EC:2.7.11.13]
K19662 PRKCB; classical protein kinase C beta type [EC:2.7.11.13]
K04718 SPHK; sphingosine kinase [EC:2.7.1.91]
K02833 HRAS; GTPase HRas
K07827 KRAS; GTPase KRas
K07828 NRAS; GTPase NRas
K04366 RAF1; RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K04368 MAP2K1; mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
K04369 MAP2K2; mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
K04371 ERK; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K06268 PPP3R; serine/threonine-protein phosphatase 2B regulatory subunit
K17332 NFATC2; nuclear factor of activated T-cells, cytoplasmic 2
K11987 PTGS2; prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1]
K05725 PTK2; focal adhesion kinase 1 [EC:2.7.10.2]
K17447 SHC2; SHC-transforming protein 2
K05760 PXN; paxillin
K04393 CDC42; cell division control protein 42
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04443 MAPKAPK2; mitogen-activated protein kinase-activated protein kinase 2 [EC:2.7.11.1]
K04444 MAPKAPK3; mitogen-activated protein kinase-activated protein kinase 3 [EC:2.7.11.1]
K04455 HSPB1; heat shock protein beta-1
K05704 SRC; tyrosine-protein kinase Src [EC:2.7.10.2]
K00922 PIK3CA_B_D; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta [EC:2.7.1.153]
K00922 PIK3CA_B_D; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta [EC:2.7.1.153]
K00922 PIK3CA_B_D; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta [EC:2.7.1.153]
K02649 PIK3R1_2_3; phosphoinositide-3-kinase regulatory subunit alpha/beta/delta
K02649 PIK3R1_2_3; phosphoinositide-3-kinase regulatory subunit alpha/beta/delta
K02649 PIK3R1_2_3; phosphoinositide-3-kinase regulatory subunit alpha/beta/delta
K04392 RAC1; Ras-related C3 botulinum toxin substrate 1
K07860 RAC2; Ras-related C3 botulinum toxin substrate 2
K07861 RAC3; Ras-related C3 botulinum toxin substrate 3
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04399 CASP9; caspase 9 [EC:3.4.22.62]
     04371 Apelin signaling pathway [PATH:gga04371]
     04630 Jak-STAT signaling pathway
     04064 NF-kappa B signaling pathway
     04668 TNF signaling pathway
     04066 HIF-1 signaling pathway
     04068 FoxO signaling pathway [PATH:gga04068]
     04020 Calcium signaling pathway [PATH:gga04020]
     04070 Phosphatidylinositol signaling system [PATH:gga04070]
     04072 Phospholipase D signaling pathway
     04071 Sphingolipid signaling pathway
     04024 cAMP signaling pathway
     04022 cGMP - PKG signaling pathway
     04151 PI3K-Akt signaling pathway
     04152 AMPK signaling pathway
     04150 mTOR signaling pathway [PATH:gga04150]
     04075 Plant hormone signal transduction
 
   Signaling molecules and interaction
 
 Cellular Processes
 
 Organismal Systems
 
   Immune system
     04640 Hematopoietic cell lineage
     04610 Complement and coagulation cascades
     04611 Platelet activation
     04620 Toll-like receptor signaling pathway [PATH:gga04620]
     04624 Toll and Imd signaling pathway
     04621 NOD-like receptor signaling pathway [PATH:gga04621]
     04622 RIG-I-like receptor signaling pathway [PATH:gga04622]
     04623 Cytosolic DNA-sensing pathway [PATH:gga04623]
     04625 C-type lectin receptor signaling pathway [PATH:gga04625]
       374254 LSP1; lymphocyte-specific protein 1
       396229 HRAS; GTPase HRas precursor
       418207 KRAS; GTPase KRas
       419885 NRAS; GTPase NRas precursor
       395149 MRAS; ras-related protein M-Ras
       423062 RRAS2; ras-related protein R-Ras2
       396245 RAF1; RAF proto-oncogene serine/threonine-protein kinase
       396027 RELA; transcription factor p65
       407090 IL12A; interleukin-12 subunit alpha precursor
       404671 IL12B; interleukin-12 subunit beta precursor
       395196 IL1B; interleukin-1 beta
       427272 SYK; tyrosine-protein kinase SYK
       395815 PTPN11; tyrosine-protein phosphatase non-receptor type 11
       419429 protein tyrosine phosphatase
       419964 MAP3K14; mitogen-activated protein kinase kinase kinase 14
       423669 CHUK; inhibitor of nuclear factor kappa-B kinase subunit alpha
       386574 NFKB2; nuclear factor NF-kappa-B p100 subunit
       415805 PLCG2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2
       395412 ITPR1; inositol 1,4,5-trisphosphate receptor type 1
       418212 ITPR2; inositol 1,4,5-trisphosphate receptor type 2 isoform X1
       419910 ITPR3; inositol 1,4,5-trisphosphate receptor type 3 isoform X1
       396523 CALM1; neo-calmodulin
       416692 CALML3; calmodulin, striated muscle
       395855 CALM2; calmodulin
       427515 CALML4; calmodulin-like protein 4
       378890 PPP3CB; serine/threonine-protein phosphatase 2B catalytic subunit beta isoform
       395113 PPP3CA; serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X1
       378804 PPP3R1; calcineurin subunit B type 1
       420815 NFATC1; nuclear factor of activated T-cells, cytoplasmic 1 isoform X9
       419346 NFATC2; nuclear factor of activated T-cells, cytoplasmic 2 isoform X2
       415711 NFATC3; nuclear factor of activated T-cells, cytoplasmic 3 isoform X1
       373958 IL2; interleukin 2 precursor
       428264 IL10; interleukin-10 precursor
       102725543 EGR3; early growth response protein 3 isoform X1
       396451 PTGS2; prostaglandin G/H synthase 2 isoform 1 precursor
       415905 PRKCD; protein kinase C delta type
       373953 MAPK1; mitogen-activated protein kinase 1
       423021 NLRPL; NACHT, LRR and PYD domains-containing protein 3
       395764 CASP1; caspase-1 isoform X1
       427756 CARD9; caspase recruitment domain-containing protein 9 isoform X2
       424528 BCL10; B-cell lymphoma/leukemia 10
       429451 PCASP2; paracaspase-2
       415336 PCASP3; mucosa-associated lymphoid tissue lymphoma translocation protein 1 isoform X3
       426852 PCASP1; mucosa-associated lymphoid tissue lymphoma translocation protein 1 isoform X2
       395284 CASP8; caspase-8
       426792 IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta
       396093 NFKBIA; NF-kappa-B inhibitor alpha
       396033 NFKB1; nuclear factor NF-kappa-B p105 subunit
       395337 IL6; interleukin-6 precursor
       100858964 IL23A; interleukin-23 subunit alpha
       417739 MAPK11; mitogen-activated protein kinase 11
       421183 MAPK14; mitogen-activated protein kinase 14 isoform X1
       769763 MAPK12; mitogen-activated protein kinase 12
       771145 MAPK13; mitogen-activated protein kinase 13 isoform X1
       423778 MAPK8; mitogen-activated protein kinase 8 isoform X1
       395983 MAPK9; mitogen-activated protein kinase 9
       422592 MAPK10; mitogen-activated protein kinase 10 isoform 1
       424673 JUN; transcription factor AP-1
       418406 CBLB; E3 ubiquitin-protein ligase CBL-B isoform X2
       100049618 FCER1G; high affinity immunoglobulin epsilon receptor subunit gamma precursor
       419752 ARHGEF12; rho guanine nucleotide exchange factor 12 isoform X2
       395442 RHOA; transforming protein RhoA
       419083 PAK1; serine/threonine-protein kinase PAK 1
       427839 KSR1; kinase suppressor of Ras 1 isoform X2
       424586 PLK3; serine/threonine-protein kinase PLK3 isoform X1
       396442 SRC; proto-oncogene tyrosine-protein kinase Src
       430480 IKBKE; inhibitor of nuclear factor kappa-B kinase subunit epsilon isoform X4
       424044 STAT1; signal transducer and activator of transcription 1-alpha/beta
       100858732 STAT2; signal transducer and activator of transcription 2 isoform X1
       415725 CYLD; LOW QUALITY PROTEIN: ubiquitin carboxyl-terminal hydrolase CYLD
       420294 ubiquitin carboxyl-terminal hydrolase CYLD
       415652 CCL17; chemokine (C-C motif) ligand 17 precursor
       419847 MAPKAPK2; MAP kinase-activated protein kinase 2 isoform X1
       424971 PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
       419444 PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
       424826 PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
       429096 PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma isoform X2
       771142 PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta
       427171 PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X2
       395928 AKT1; RAC-alpha serine/threonine-protein kinase
       421497 AKT3; RAC-gamma serine/threonine-protein kinase isoform X1
       395609 MDM2; E3 ubiquitin-protein ligase Mdm2
       396384 IRF1; interferon regulatory factor 1
K14957 LSP1; lymphocyte-specific protein 1
K02833 HRAS; GTPase HRas
K07827 KRAS; GTPase KRas
K07828 NRAS; GTPase NRas
K07831 MRAS; Ras-related protein M-Ras
K07830 RRAS2; Ras-related protein R-Ras2
K04366 RAF1; RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K04735 RELA; transcription factor p65
K05406 IL12A; interleukin 12A
K05425 IL12B; interleukin 12B
K04519 IL1B; interleukin 1 beta
K05855 SYK; spleen tyrosine kinase [EC:2.7.10.2]
K07293 PTPN11; tyrosine-protein phosphatase non-receptor type 11 [EC:3.1.3.48]
K07293 PTPN11; tyrosine-protein phosphatase non-receptor type 11 [EC:3.1.3.48]
K04466 MAP3K14; mitogen-activated protein kinase kinase kinase 14 [EC:2.7.11.25]
K04467 IKBKA; inhibitor of nuclear factor kappa-B kinase subunit alpha [EC:2.7.11.10]
K04469 NFKB2; nuclear factor of kappa light polypeptide gene enhancer in B-cells 2
K05859 PLCG2; phosphatidylinositol phospholipase C, gamma-2 [EC:3.1.4.11]
K04958 ITPR1; inositol 1,4,5-triphosphate receptor type 1
K04959 ITPR2; inositol 1,4,5-triphosphate receptor type 2
K04960 ITPR3; inositol 1,4,5-triphosphate receptor type 3
K02183 CALM; calmodulin
K02183 CALM; calmodulin
K02183 CALM; calmodulin
K02183 CALM; calmodulin
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K06268 PPP3R; serine/threonine-protein phosphatase 2B regulatory subunit
K04446 NFATC1; nuclear factor of activated T-cells, cytoplasmic 1
K17332 NFATC2; nuclear factor of activated T-cells, cytoplasmic 2
K17333 NFATC3; nuclear factor of activated T-cells, cytoplasmic 3
K05429 IL2; interleukin 2
K05443 IL10; interleukin 10
K12497 EGR3; early growth response protein 3
K11987 PTGS2; prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1]
K06068 PRKCD; novel protein kinase C delta type [EC:2.7.11.13]
K04371 ERK; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K12800 NLRP3; NACHT, LRR and PYD domains-containing protein 3
K01370 CASP1; caspase 1 [EC:3.4.22.36]
K12794 CARD9; caspase recruitment domain-containing protein 9
K07368 BCL10; B-cell CLL/lymphoma 10
K07369 MALT1; mucosa-associated lymphoid tissue lymphoma translocation protein 1 [EC:3.4.22.-]
K07369 MALT1; mucosa-associated lymphoid tissue lymphoma translocation protein 1 [EC:3.4.22.-]
K07369 MALT1; mucosa-associated lymphoid tissue lymphoma translocation protein 1 [EC:3.4.22.-]
K04398 CASP8; caspase 8 [EC:3.4.22.61]
K07209 IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10]
K04734 NFKBIA; NF-kappa-B inhibitor alpha
K02580 NFKB1; nuclear factor NF-kappa-B p105 subunit
K05405 IL6; interleukin 6
K05426 IL23A; interleukin 23 subunit alpha
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04440 JNK; mitogen-activated protein kinase 8/9/10 (c-Jun N-terminal kinase) [EC:2.7.11.24]
K04440 JNK; mitogen-activated protein kinase 8/9/10 (c-Jun N-terminal kinase) [EC:2.7.11.24]
K04440 JNK; mitogen-activated protein kinase 8/9/10 (c-Jun N-terminal kinase) [EC:2.7.11.24]
K04448 JUN; transcription factor AP-1
K22517 CBLB; E3 ubiquitin-protein ligase CBL-B [EC:2.3.2.27]
K07983 FCER1G; high affinity immunoglobulin epsilon receptor subunit gamma
K07532 ARHGEF12; Rho guanine nucleotide exchange factor 12
K04513 RHOA; Ras homolog gene family, member A
K04409 PAK1; p21-activated kinase 1 [EC:2.7.11.1]
K14958 KSR1; kinase suppressor of Ras 1
K08862 PLK3; polo-like kinase 3 [EC:2.7.11.21]
K05704 SRC; tyrosine-protein kinase Src [EC:2.7.10.2]
K07211 IKBKE; inhibitor of nuclear factor kappa-B kinase subunit epsilon [EC:2.7.11.10]
K11220 STAT1; signal transducer and activator of transcription 1
K11221 STAT2; signal transducer and activator of transcription 2
K08601 CYLD; ubiquitin thioesterase [EC:3.4.19.12]
K08601 CYLD; ubiquitin thioesterase [EC:3.4.19.12]
K21083 CCL17; C-C motif chemokine 17
K04443 MAPKAPK2; mitogen-activated protein kinase-activated protein kinase 2 [EC:2.7.11.1]
K00922 PIK3CA_B_D; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta [EC:2.7.1.153]
K00922 PIK3CA_B_D; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta [EC:2.7.1.153]
K00922 PIK3CA_B_D; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta [EC:2.7.1.153]
K02649 PIK3R1_2_3; phosphoinositide-3-kinase regulatory subunit alpha/beta/delta
K02649 PIK3R1_2_3; phosphoinositide-3-kinase regulatory subunit alpha/beta/delta
K02649 PIK3R1_2_3; phosphoinositide-3-kinase regulatory subunit alpha/beta/delta
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K06643 MDM2; E3 ubiquitin-protein ligase Mdm2 [EC:2.3.2.27]
K09444 IRF1; interferon regulatory factor 1
     04650 Natural killer cell mediated cytotoxicity
     04612 Antigen processing and presentation
     04660 T cell receptor signaling pathway
     04658 Th1 and Th2 cell differentiation
     04659 Th17 cell differentiation
     04657 IL-17 signaling pathway
     04662 B cell receptor signaling pathway
     04664 Fc epsilon RI signaling pathway
     04666 Fc gamma R-mediated phagocytosis
     04670 Leukocyte transendothelial migration
     04672 Intestinal immune network for IgA production [PATH:gga04672]
     04062 Chemokine signaling pathway
     04054 Pattern recognition receptors [BR:gga04054]
 
   Endocrine system
 
   Circulatory system
 
   Digestive system
 
   Excretory system
 
   Nervous system
 
   Sensory system
 
   Development
 
   Aging
 
   Environmental adaptation
 
 Human Diseases
 
   Cancers
 
   Immune diseases
 
   Neurodegenerative diseases
 
   Substance dependence
 
   Cardiovascular diseases
 
   Endocrine and metabolic diseases
 
   Infectious diseases
     05110 Vibrio cholerae infection
     05120 Epithelial cell signaling in Helicobacter pylori infection
     05130 Pathogenic Escherichia coli infection
     05132 Salmonella infection [PATH:gga05132]
     05131 Shigellosis
     05133 Pertussis
     05134 Legionellosis
     05150 Staphylococcus aureus infection
     05152 Tuberculosis
     05100 Bacterial invasion of epithelial cells
     05166 HTLV-I infection
     05162 Measles
     05164 Influenza A [PATH:gga05164]
     05161 Hepatitis B
     05160 Hepatitis C
     05168 Herpes simplex infection [PATH:gga05168]
     05163 Human cytomegalovirus infection
       395509 PDGFRA; platelet-derived growth factor receptor alpha precursor
       424971 PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
       419444 PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
       424826 PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
       429096 PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma isoform X2
       771142 PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta
       427171 PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X2
       395928 AKT1; RAC-alpha serine/threonine-protein kinase
       421497 AKT3; RAC-gamma serine/threonine-protein kinase isoform X1
       417166 TSC1; hamartin isoform X2
       416552 TSC2; tuberin isoform X1
       420434 RHEB; GTP-binding protein Rheb isoform X1
       419455 MTOR; serine/threonine-protein kinase mTOR
       426773 EIF4EBP1; eukaryotic translation initiation factor 4E-binding protein 1
       417637 RPS6KB1; ribosomal protein S6 kinase beta-1
       429557 RPS6KB2; ribosomal protein S6 kinase beta-2 isoform X5
       423669 CHUK; inhibitor of nuclear factor kappa-B kinase subunit alpha
       426792 IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta
       396033 NFKB1; nuclear factor NF-kappa-B p105 subunit
       396027 RELA; transcription factor p65
       396494 EGFR; epidermal growth factor receptor precursor
       386572 GRB2; growth factor receptor-bound protein 2
       423572 SOS2; son of sevenless homolog 2
       431192 SOS1; son of sevenless homolog 1
       396229 HRAS; GTPase HRas precursor
       418207 KRAS; GTPase KRas
       419885 NRAS; GTPase NRas precursor
       396245 RAF1; RAF proto-oncogene serine/threonine-protein kinase
       415549 MAP2K1; dual specificity mitogen-activated protein kinase kinase 1
       396349 MAP2K2; dual specificity mitogen-activated protein kinase kinase 2
       373953 MAPK1; mitogen-activated protein kinase 1
       395303 SP1; transcription factor Sp1
       396420 ITGAV; integrin alpha-V precursor
       374209 ITGB3; integrin beta-3 precursor
       396442 SRC; proto-oncogene tyrosine-protein kinase Src
       395871 RAC1; ras-related C3 botulinum toxin substrate 1
       418044 RAC2; ras-related C3 botulinum toxin substrate 2
       395870 RAC3; ras-related C3 botulinum toxin substrate 3
       395442 RHOA; transforming protein RhoA
       421864 MB21D1; cyclic GMP-AMP synthase
       768990 TMEM173; stimulator of interferon genes protein
       417825 TBK1; serine/threonine-protein kinase TBK1
       768614 IFA3L; interferon type A3
       396398 IFNA3; interferon type A1/A2 precursor
       100859032 IFNAL6; interferon type A1/A2
       100858177 interferon type A1/A2
       100857947 IFNAL5; interferon type A1/A2
       100857744 IFNAL4; interferon type A1/A2
       101750245 IFNKL1; interferon kappa isoform X2
       554219 IFNW1; interferon type B precursor
       418325 TNFRSF1A; tumor necrosis factor receptor superfamily member 1A precursor
       378921 RIPK1; receptor-interacting serine/threonine-protein kinase 1
       415700 TRADD; tumor necrosis factor receptor type 1-associated DEATH domain protein
       374055 TRAF5; TNF receptor-associated factor 5
       417287 TRAF2; TNF receptor-associated factor 2 isoform X1
       395196 IL1B; interleukin-1 beta
       396481 IL1R1; interleukin-1 receptor type 1 precursor
       396093 NFKBIA; NF-kappa-B inhibitor alpha
       417465 CCL5; C-C motif chemokine 5 precursor
       396495 IL8L2; interleukin-8 precursor
       395872 IL8L1; interleukin-8 precursor
       395337 IL6; interleukin-6 precursor
       419402 GNB1; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1
       424974 GNB4; guanine nucleotide-binding protein subunit beta-4
       415417 GNB5; guanine nucleotide-binding protein subunit beta-5
       423581 GNG2; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2
       771582 GNG4; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4 isoform X1
       424538 GNG5; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5
       100858976 GNG7; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7 isoform X1
       769603 GNG10; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10
       771999 GNG11; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11
       772239 GNG12; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12
       771014 GNG13; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13
       100859179 GNGT2; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2
       427262 GNAQ; guanine nucleotide-binding protein G(q) subunit alpha
       374077 GNA11; guanine nucleotide-binding protein subunit alpha-11
       423014 PLCB2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 isoform X2
       416730 PLCB4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4
       427687 PLCB1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 isoform X1
       395412 ITPR1; inositol 1,4,5-trisphosphate receptor type 1
       418212 ITPR2; inositol 1,4,5-trisphosphate receptor type 2 isoform X1
       419910 ITPR3; inositol 1,4,5-trisphosphate receptor type 3 isoform X1
       396523 CALM1; neo-calmodulin
       416692 CALML3; calmodulin, striated muscle
       395855 CALM2; calmodulin
       427515 CALML4; calmodulin-like protein 4
       378890 PPP3CB; serine/threonine-protein phosphatase 2B catalytic subunit beta isoform
       395113 PPP3CA; serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X1
       378804 PPP3R1; calcineurin subunit B type 1
       420815 NFATC1; nuclear factor of activated T-cells, cytoplasmic 1 isoform X9
       419346 NFATC2; nuclear factor of activated T-cells, cytoplasmic 2 isoform X2
       415711 NFATC3; nuclear factor of activated T-cells, cytoplasmic 3 isoform X1
       396451 PTGS2; prostaglandin G/H synthase 2 isoform 1 precursor
       374097 GNAI3; guanine nucleotide-binding protein G(k) subunit alpha
       396367 GNAI2; guanine nucleotide-binding protein G(i) subunit alpha-2
       396368 GNAI1; guanine nucleotide-binding protein G(i) subunit alpha-1
       415698 GNAO1; guanine nucleotide-binding protein G(o) subunit alpha
       420788 ADCY1; adenylate cyclase type 1 isoform X1
       420935 ADCY2; adenylate cyclase type 2 isoform X1
       422013 ADCY3; adenylate cyclase type 3 isoform X1
       395340 ADCY5; adenylate cyclase type 5
       415732 ADCY7; adenylate cyclase type 7 isoform X1
       420328 ADCY8; adenylate cyclase type 8 isoform X2
       395339 ADCY9; adenylate cyclase type 9
       424542 PRKACB; cAMP-dependent protein kinase catalytic subunit beta isoform X7
       395551 CCL4; C-C motif chemokine 4 homolog precursor
       415651 CX3CL1; fractalkine precursor
       769924 GNA12; guanine nucleotide-binding protein subunit alpha-12
       417434 GNA13; guanine nucleotide-binding protein subunit alpha-13
       425979 ARHGEF11; rho guanine nucleotide exchange factor 11 isoform X1
       419752 ARHGEF12; rho guanine nucleotide exchange factor 12 isoform X2
       415502 AKAP13; A-kinase anchor protein 13 isoform X1
       373970 ROCK1; rho-associated protein kinase 1
       374182 ROCK2; rho-associated protein kinase 2 isoform X1
       395964 CTNNB1; catenin beta-1
       100034745 PTGER2; prostaglandin E2 receptor EP2 subtype
       429116 PTGER3; prostaglandin E2 receptor EP3 subtype
       427183 PTGER4; prostaglandin E2 receptor EP4 subtype
       419313 GNAS; guanine nucleotide-binding protein G(s) subunit alpha isoform X1
       418335 GSK3B; glycogen synthase kinase-3 beta isoform X2
       396341 CCND1; G1/S-specific cyclin-D1
       420332 MYC; myc proto-oncogene protein
       693252 IL6R; interleukin-6 receptor subunit alpha precursor
       395681 JAK1; tyrosine-protein kinase JAK1
       420027 STAT3; signal transducer and activator of transcription 3
       395909 VEGFA; vascular endothelial growth factor A isoform 1 precursor
       417445 MAP2K6; dual specificity mitogen-activated protein kinase kinase 6 isoform X1
       417739 MAPK11; mitogen-activated protein kinase 11
       421183 MAPK14; mitogen-activated protein kinase 14 isoform X1
       769763 MAPK12; mitogen-activated protein kinase 12
       771145 MAPK13; mitogen-activated protein kinase 13 isoform X1
       395099 CREB1; cyclic AMP-responsive element-binding protein 1
       395727 ATF2; cyclic AMP-dependent transcription factor ATF-2
       395693 ATF4; cyclic AMP-dependent transcription factor ATF-4
       427417 CREB3; cyclic AMP-responsive element-binding protein 3
       418123 CREB3L2; cyclic AMP-responsive element-binding protein 3-like protein 2 isoform X2
       428333 CREB3L3; cyclic AMP-responsive element-binding protein 3-like protein 3 isoform X1
       100859610 CREB3L1; cyclic AMP-responsive element-binding protein 3-like protein 1 isoform X2
       428435 CREB5; cyclic AMP-responsive element-binding protein 5 isoform X3
       395180 CXCL12; stromal cell-derived factor 1 precursor
       395324 CXCR4; C-X-C chemokine receptor type 4
       417430 PRKCA; protein kinase C alpha type
       416567 PRKCB; protein kinase C beta type isoform X1
       421998 PTK2B; protein-tyrosine kinase 2-beta isoform X2
       396416 PTK2; focal adhesion kinase 1
       415691 BCAR1; breast cancer anti-estrogen resistance protein 1 isoform X1
       416939 CRKL; crk-like protein
       107054794 CRK; CRK proto-oncogene, adaptor protein
       395832 PXN; paxillin
       419771 IL10RA; interleukin-10 receptor subunit alpha precursor
       395663 IL10RB; interleukin-10 receptor subunit beta precursor
       430652 CXCR1; C-X-C chemokine receptor type 2
       420696 CCR2; C-C chemokine receptor type 2
       420695 CCR5; C-C chemokine receptor type 5
       427727 TAP1; antigen peptide transporter 1
       427728 TAP2; antigen peptide transporter 2
       417048 TAPBP; tapasin isoform 1 precursor
       373899 PDIA3; protein disulfide-isomerase A3 precursor
       100859104 CALR; calreticulin
       417057 MHCIA6; class I histocompatibility antigen, F10 alpha chain
       425389 BF2; Major histocompatibility complex class I antigen BF2 precursor
       427746 YF5; MHC class I antigen YF5 precursor
       693260 BF1; MHC BF1 class I precursor
       414830 B2M; beta-2-microglobulin precursor
       395609 MDM2; E3 ubiquitin-protein ligase Mdm2
       378914 CDKN1A; cyclin-dependent kinase inhibitor 1
       420558 CDK6; cyclin-dependent kinase 6
       386582 RB1; retinoblastoma-associated protein
       396142 E2F1; transcription factor E2F1
       425366 E2F2; LOW QUALITY PROTEIN: transcription factor E2F2
       420824 E2F3; transcription factor E2F3 isoform X2
       429064 FASLG; tumor necrosis factor ligand superfamily member 6
       395274 FAS; tumor necrosis factor receptor superfamily member 6 precursor
       423146 FADD; FAS-associated death domain protein
       395284 CASP8; caspase-8
       395236 BID; BH3-interacting domain death agonist
       419912 BAK1; bcl-2 homologous antagonist/killer
       420624 CYCS; cytochrome c
       426970 CASP9; caspase-9
       395476 CASP3; caspase-3
K04363 PDGFRA; platelet-derived growth factor receptor alpha [EC:2.7.10.1]
K00922 PIK3CA_B_D; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta [EC:2.7.1.153]
K00922 PIK3CA_B_D; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta [EC:2.7.1.153]
K00922 PIK3CA_B_D; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta [EC:2.7.1.153]
K02649 PIK3R1_2_3; phosphoinositide-3-kinase regulatory subunit alpha/beta/delta
K02649 PIK3R1_2_3; phosphoinositide-3-kinase regulatory subunit alpha/beta/delta
K02649 PIK3R1_2_3; phosphoinositide-3-kinase regulatory subunit alpha/beta/delta
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K07206 TSC1; tuberous sclerosis 1
K07207 TSC2; tuberous sclerosis 2
K07208 RHEB; Ras homolog enriched in brain
K07203 MTOR; serine/threonine-protein kinase mTOR [EC:2.7.11.1]
K07205 EIF4EBP1; eukaryotic translation initiation factor 4E binding protein 1
K04688 RPS6KB; ribosomal protein S6 kinase beta [EC:2.7.11.1]
K04688 RPS6KB; ribosomal protein S6 kinase beta [EC:2.7.11.1]
K04467 IKBKA; inhibitor of nuclear factor kappa-B kinase subunit alpha [EC:2.7.11.10]
K07209 IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10]
K02580 NFKB1; nuclear factor NF-kappa-B p105 subunit
K04735 RELA; transcription factor p65
K04361 EGFR; epidermal growth factor receptor [EC:2.7.10.1]
K04364 GRB2; growth factor receptor-binding protein 2
K03099 SOS; son of sevenless
K03099 SOS; son of sevenless
K02833 HRAS; GTPase HRas
K07827 KRAS; GTPase KRas
K07828 NRAS; GTPase NRas
K04366 RAF1; RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K04368 MAP2K1; mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
K04369 MAP2K2; mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
K04371 ERK; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04684 SP1; transcription factor Sp1
K06487 ITGAV; integrin alpha V
K06493 ITGB3; integrin beta 3
K05704 SRC; tyrosine-protein kinase Src [EC:2.7.10.2]
K04392 RAC1; Ras-related C3 botulinum toxin substrate 1
K07860 RAC2; Ras-related C3 botulinum toxin substrate 2
K07861 RAC3; Ras-related C3 botulinum toxin substrate 3
K04513 RHOA; Ras homolog gene family, member A
K17834 MB21D1; cyclic GMP-AMP synthase [EC:2.7.7.86]
K12654 TMEM173; transmembrane protein 173
K05410 TBK1; TANK-binding kinase 1 [EC:2.7.11.10]
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05415 IFNB; interferon beta
K03158 TNFRSF1A; tumor necrosis factor receptor superfamily member 1A
K02861 RIPK1; receptor-interacting serine/threonine-protein kinase 1 [EC:2.7.11.1]
K03171 TRADD; tumor necrosis factor receptor type 1-associated DEATH domain protein
K09849 TRAF5; TNF receptor-associated factor 5
K03173 TRAF2; TNF receptor-associated factor 2 [EC:2.3.2.27]
K04519 IL1B; interleukin 1 beta
K04386 IL1R1; interleukin 1 receptor type I
K04734 NFKBIA; NF-kappa-B inhibitor alpha
K12499 CCL5; C-C motif chemokine 5
K10030 IL8; interleukin 8
K10030 IL8; interleukin 8
K05405 IL6; interleukin 6
K04536 GNB1; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1
K04538 GNB4; guanine nucleotide-binding protein subunit beta-4
K04539 GNB5; guanine nucleotide-binding protein subunit beta-5
K07826 GNG2; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2
K04541 GNG4; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4
K04542 GNG5; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5
K04543 GNG7; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7
K04545 GNG10; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10
K04546 GNG11; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11
K04347 GNG12; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12
K04547 GNG13; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13
K04549 GNGT2; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2
K04634 GNAQ; guanine nucleotide-binding protein G(q) subunit alpha
K04635 GNA11; guanine nucleotide-binding protein subunit alpha-11
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K04958 ITPR1; inositol 1,4,5-triphosphate receptor type 1
K04959 ITPR2; inositol 1,4,5-triphosphate receptor type 2
K04960 ITPR3; inositol 1,4,5-triphosphate receptor type 3
K02183 CALM; calmodulin
K02183 CALM; calmodulin
K02183 CALM; calmodulin
K02183 CALM; calmodulin
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K04348 PPP3C; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K06268 PPP3R; serine/threonine-protein phosphatase 2B regulatory subunit
K04446 NFATC1; nuclear factor of activated T-cells, cytoplasmic 1
K17332 NFATC2; nuclear factor of activated T-cells, cytoplasmic 2
K17333 NFATC3; nuclear factor of activated T-cells, cytoplasmic 3
K11987 PTGS2; prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1]
K04630 GNAI; guanine nucleotide-binding protein G(i) subunit alpha
K04630 GNAI; guanine nucleotide-binding protein G(i) subunit alpha
K04630 GNAI; guanine nucleotide-binding protein G(i) subunit alpha
K04534 GNAO; guanine nucleotide-binding protein G(o) subunit alpha
K08041 ADCY1; adenylate cyclase 1 [EC:4.6.1.1]
K08042 ADCY2; adenylate cyclase 2 [EC:4.6.1.1]
K08043 ADCY3; adenylate cyclase 3 [EC:4.6.1.1]
K08045 ADCY5; adenylate cyclase 5 [EC:4.6.1.1]
K08047 ADCY7; adenylate cyclase 7 [EC:4.6.1.1]
K08048 ADCY8; adenylate cyclase 8 [EC:4.6.1.1]
K08049 ADCY9; adenylate cyclase 9 [EC:4.6.1.1]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K12964 CCL4; C-C motif chemokine 4
K05508 CX3CL1; C-X3-C motif chemokine 1
K04346 GNA12; guanine nucleotide-binding protein subunit alpha-12
K04639 GNA13; guanine nucleotide-binding protein subunit alpha-13
K12331 ARHGEF11; Rho guanine nucleotide exchange factor 11
K07532 ARHGEF12; Rho guanine nucleotide exchange factor 12
K16529 ARHGEF13; A-kinase anchor protein 13
K04514 ROCK1; Rho-associated protein kinase 1 [EC:2.7.11.1]
K17388 ROCK2; Rho-associated protein kinase 2 [EC:2.7.11.1]
K02105 CTNNB1; catenin beta 1
K04259 PTGER2; prostaglandin E receptor 2
K04260 PTGER3; prostaglandin E receptor 3
K04261 PTGER4; prostaglandin E receptor 4
K04632 GNAS; guanine nucleotide-binding protein G(s) subunit alpha
K03083 GSK3B; glycogen synthase kinase 3 beta [EC:2.7.11.26]
K04503 CCND1; G1/S-specific cyclin-D1
K04377 MYC; Myc proto-oncogene protein
K05055 IL6R; interleukin 6 receptor
K11217 JAK1; Janus kinase 1 [EC:2.7.10.2]
K04692 STAT3; signal transducer and activator of transcription 3
K05448 VEGFA; vascular endothelial growth factor A
K04433 MAP2K6; mitogen-activated protein kinase kinase 6 [EC:2.7.12.2]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K05870 CREB1; cyclic AMP-responsive element-binding protein 1
K04450 ATF2; cyclic AMP-dependent transcription factor ATF-2
K04374 ATF4; cyclic AMP-dependent transcription factor ATF-4
K09048 CREB3; cyclic AMP-responsive element-binding protein 3
K09048 CREB3; cyclic AMP-responsive element-binding protein 3
K09048 CREB3; cyclic AMP-responsive element-binding protein 3
K09048 CREB3; cyclic AMP-responsive element-binding protein 3
K09047 CREB5; cyclic AMP-responsive element-binding protein 5
K10031 CXCL12; C-X-C motif chemokine 12
K04189 CXCR4; C-X-C chemokine receptor type 4
K02677 PRKCA; classical protein kinase C alpha type [EC:2.7.11.13]
K19662 PRKCB; classical protein kinase C beta type [EC:2.7.11.13]
K05871 PTK2B; focal adhesion kinase 2 [EC:2.7.10.2]
K05725 PTK2; focal adhesion kinase 1 [EC:2.7.10.2]
K05726 BCAR1; breast cancer anti-estrogen resistance 1
K04438 CRK; proto-oncogene C-crk
K04438 CRK; proto-oncogene C-crk
K05760 PXN; paxillin
K05134 IL10RA; interleukin 10 receptor alpha
K05135 IL10RB; interleukin 10 receptor beta
K05050 CXCR2; C-X-C chemokine receptor type 2
K04180 CCR5; C-C chemokine receptor type 5
K04180 CCR5; C-C chemokine receptor type 5
K05653 ABCB2; ATP-binding cassette, subfamily B (MDR/TAP), member 2
K05654 ABCB3; ATP-binding cassette, subfamily B (MDR/TAP), member 3
K08058 TAPBP; TAP binding protein (tapasin)
K08056 PDIA3; protein disulfide isomerase family A, member 3 [EC:5.3.4.1]
K08057 CALR; calreticulin
K06751 MHC1; major histocompatibility complex, class I
K06751 MHC1; major histocompatibility complex, class I
K06751 MHC1; major histocompatibility complex, class I
K06751 MHC1; major histocompatibility complex, class I
K08055 B2M; beta-2-microglobulin
K06643 MDM2; E3 ubiquitin-protein ligase Mdm2 [EC:2.3.2.27]
K06625 CDKN1A; cyclin-dependent kinase inhibitor 1A
K02091 CDK6; cyclin-dependent kinase 6 [EC:2.7.11.22]
K06618 RB1; retinoblastoma-associated protein
K17454 E2F1; transcription factor E2F1
K09389 E2F2; transcription factor E2F2
K06620 E2F3; transcription factor E2F3
K04389 TNFSF6; tumor necrosis factor ligand superfamily member 6
K04390 TNFRSF6; tumor necrosis factor receptor superfamily member 6
K02373 FADD; FAS-associated death domain protein
K04398 CASP8; caspase 8 [EC:3.4.22.61]
K04726 BID; BH3 interacting domain death agonist
K14021 BAK; Bcl-2 homologous antagonist/killer
K08738 CYC; cytochrome c
K04399 CASP9; caspase 9 [EC:3.4.22.62]
K02187 CASP3; caspase 3 [EC:3.4.22.56]
     05167 Kaposi's sarcoma-associated herpesvirus infection
     05169 Epstein-Barr virus infection
     05165 Human papillomavirus infection
     03200 Viral proteins
     05146 Amoebiasis
     05144 Malaria
     05145 Toxoplasmosis
     05140 Leishmaniasis
     05142 Chagas disease (American trypanosomiasis)
     05143 African trypanosomiasis
 
   Drug resistance

[ KO | BRITE | KEGG2 | KEGG ]
Last updated: June 20, 2018

» All categories